Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 140

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 3
Chunk 140
---
 on February 19, 2025)

    10.2
     
    Form
of Exchange Agreement (incorporated herein by reference to Exhibit 99.1 to Form 8-K filed with the SEC on July 9, 2025)

    31.1**
     
    Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 

    31.2** 
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 

    32.1***
     
    Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350

    32.2***
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350

    101.INS 
     
    XBRL Instance Document

    101.SCH 
     
    XBRL Taxonomy Extension Schema

    101.CAL 
     
    XBRL Taxonomy Extension Calculation Linkbase

    101.DEF 
     
    XBRL Taxonomy Extension Definition Linkbase

    101.LAB 
     
    XBRL Taxonomy Extension Label Linkbase

    101.PRE 
     
    XBRL Taxonomy Extension Presentation Linkbase

    **
    Filed herewith. 
  
    ***
    Furnished herewith. 
  
    †
    Denotes a management contract or compensatory plan or arrangement

39

SIGNATURES

Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

    Date: November 14, 2025
    LUNAI BIOWORKS INC. 

    By: 
    /s/ David Weinstein

    David Weinstein 

    Chief Executive Officer 

    (Principal Executive Officer) 

    By: 
    /s/ Nathen Fuentes

    Nathen Fuentes